Conceptio
›
multiple-myeloma
Topic
multiple-myeloma
Knowledge-graph topic
· documents ABOUT multiple-myeloma across the archive
675
Documents about multiple-myeloma
Documents about multiple-myeloma
Novel BCMA-targeted CAR-T Cell Therapy for Multiple Myeloma
#919047
ClinicalTrials.gov
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
#980745
ClinicalTrials.gov
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
#830982
ClinicalTrials.gov
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
#992559
ClinicalTrials.gov
A Study of PVX-410, a Cancer Vaccine, and Citarinostat +/- Lenalidomide for Smoldering MM
#869132
ClinicalTrials.gov
Pomalidomide-Cyclophosphamide-Dexamethasone (PCD) Versus Pomalidomide-Dexamethasone (PD) in Relapse or Refractory Myeloma
#917291
ClinicalTrials.gov
Isatuximab in Combination With Lenalidomide and Dexamethasone in High-risk Smoldering Multiple Myeloma
#969371
ClinicalTrials.gov
Immunotherapy With BCMA CAR-T Cells in Treating Patients With BCMA Positive Relapsed or Refractory Multiple Myeloma
#830407
ClinicalTrials.gov
UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus
#855479
ClinicalTrials.gov
Clinical Trial to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in Patients With Relapsed and Refractory (R/R) Multiple Myeloma
#883306
ClinicalTrials.gov
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
#906511
ClinicalTrials.gov
DVRd in the Treatment of Patients With Newly Diagnosed Double-hit Multiple Myeloma
#909362
ClinicalTrials.gov
Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib
#912483
ClinicalTrials.gov
International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab
#800342
ClinicalTrials.gov
Multi-Center Study of GSK2857916 in Combination With Pomalidomide and Dex
#826869
ClinicalTrials.gov
Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients
#870573
ClinicalTrials.gov
Effects of Hyperbaric Oxygen (HBO) on Blood Count Recovery After Autologous Hematopoietic Stem Cell (HSPC) Transplant for Multiple Myeloma
#873615
ClinicalTrials.gov
Pembrolizumab in Treating Patients With Intermediate or High-Risk Smoldering Multiple Myeloma
#873909
ClinicalTrials.gov
MRI in Multiple Myeloma: Analysis of the Axial Skeleton Versus Whole Body. What is the Required Analysis?
#891625
ClinicalTrials.gov
Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients
#810571
ClinicalTrials.gov
Autologous Stem Cell Transplantation for Myeloma Patients Over 65 Years
#876531
ClinicalTrials.gov
Vismodegib After Stem Cell Transplant in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma
#895677
ClinicalTrials.gov
Targeting the immunological synapse in multiple myeloma.
#297334
NCBI PubMed Central
Social determinants of health associated with multiple myeloma incidence and survival among a low-income cohort in the Southeastern U.S.
#9875
PubMed
Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in France
#268597
HAL (France)
A Single-center Exploratory Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of a BCMA-targeted Universal LCAR-BCX Cells in Patients With Relapsed/Refractory Multiple Myeloma
#811404
ClinicalTrials.gov
Cyclophosphamide as Graft-versus-host Prophylaxis After Allogeneic Stem Cell Transplantation for Multiple Myeloma
#847763
ClinicalTrials.gov
A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients
#869929
ClinicalTrials.gov
A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Relapsed and Refractory Multiple Myeloma (RRMM)
#878892
ClinicalTrials.gov
Selinexor Plus High-Dose Melphalan (HDM) Before Autologous Hematopoietic Cell Transplantation for Multiple Myeloma
#880624
ClinicalTrials.gov
Clinical Study to Evaluate the Safety and Efficacy of IM21 CAR-T Cells in the Treatment of Elderly Patients With Relapsed or Refractory Multiple Myeloma
#888742
ClinicalTrials.gov
A Study of Atezolizumab (Anti-Programmed Death-Ligand 1 [PD-L1] Antibody) Alone or in Combination With an Immunomodulatory Drug and/or Daratumumab in Participants With Multiple Myeloma (MM)
#967968
ClinicalTrials.gov
Daratumumab, Azacitidine, and Dexamethasone for Treatment of Patients With Recurrent or Refractory Multiple Myeloma Previously Treated With Daratumumab
#918125
ClinicalTrials.gov
A Multicenter Open Label Phase II Study of Pomalidomide and Cyclophosphamide and Dexamethasone in Relapse/Refractory Multiple Myeloma Patients Who Were First Treated Within the IFM/DFCI 2009 Trial (PCD)
#847642
ClinicalTrials.gov
A Phase I/II Trial of Romidepsin (Depsipeptide) and Bortezomib in Patients With Relapsed Myeloma
#858880
ClinicalTrials.gov
Temporal trends in second primary malignancies among long-term survivors of multiple myeloma across treatment eras: a population-based analysis of the SEER database.
#9867
PubMed
D.T. PACE Versus High Dose Melphalan and Autologous Transplant in Patients With Previously Treated Multiple Myeloma
#838224
ClinicalTrials.gov
Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients
#863178
ClinicalTrials.gov
A Study to Evaluate the Efficacy and Safety of HLX15-IV Versus DARZALEX® in Combination with Lenalidomide-Dexamethasone (Rd) in Transplant-ineligible Patients with Newly Diagnosed Multiple Myeloma
#969044
ClinicalTrials.gov
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET
#888014
ClinicalTrials.gov
Daratumumab, Bortezomib, and Dexamethasone Followed by Daratumumab, Ixazomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
#811933
ClinicalTrials.gov
Enhanced dynamic risk stratification of smoldering multiple myeloma
#7587
HAL (France)
Patient With MMRR Treated With Belantamab Mafotidine on Monotherapy
#180405
ClinicalTrials.gov
Germline regulation of tumor evolutionary dynamics shapes multiple myeloma progression
#343630
bioRxiv / medRxiv
Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance
#674891
ClinicalTrials.gov
Early Patient Access Treatment Use Protocol CA204-220
#858461
ClinicalTrials.gov
Bortezomib Consolidation Trial
#895317
ClinicalTrials.gov
NXC-201 (formerly HBI0101) Multiple Myeloma
#980971
ClinicalTrials.gov
A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
#825384
ClinicalTrials.gov
A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma
#830756
ClinicalTrials.gov
← Previous
Page 12 of 20
Next →
Topic record
· derived from the Conceptio knowledge graph (shared subject terms across the corpus)
Conceptio Open Knowledge Archive — topic hubs link to canonical document pages with full provenance.